A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors
Clinical trial NCT05636215 · RECRUITING
Trial details
- NCT number
- NCT05636215
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2025-04-30
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.